The role of a Fertility Check depends on the type of test. MyBody-X offers biomarker panels that measure current levels of hormones (e.g., AMH, FSH) and inflammatory markers. These provide a metabolic snapshot but do not cover genetic predispositions or complex fertility factors like tubal patency or sperm quality. Evidence for such checks is often marketing-driven: they show metabolic associations, but no direct causal effect on fertility is proven. DNA tests for fertility-related genes (e.g., FTO, MTNR1B) have weak predictive value. Caveat: Without clinical interpretation, results may lead to false reassurance or unnecessary worry. For those trying to conceive, clinical evaluations (hormone panels, ultrasound) and targeted genetic tests (e.g., for CFTR mutations) are far more informative. Overall evidence is mixed: biomarkers have some relevance, but individual predictive power is limited.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-af209b13f90e8f5ac58817e1